检索历史清除

首页> Diabetologia: Clinical and Experimental Diabetes and Metabolism = Organ of the European Association for the Study of Diabetes (EASD)> SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? (vol 59, pg 1333, 2016)

SGLT2 Inhibition and cardiovascular events: why did EMPA-REG Outcomes surprise and what were the likely mechanisms? (vol 59, pg 1333, 2016)

导出原文传递

翻译打印收藏纠错

作者： Sattar, Naveed ^[1] ; McLaren, James ^[2] ; Kristensen, Soren L. ^[3] ; Preiss, David ; McMurray, John J.

作者单位： Univ Glasgow, Inst Cardiovasc & Med Sci, BHF Glasgow Cardiovasc Res Ctr, 126 Univ Ave, Glasgow G12 ^[1] Univ Oxford, Nuffield Dept Populat Hlth, Clin Trial Serv Unit, Oxford, England ^[2] Gentofte Univ Hosp, Dept Cardiol, Copenhagen, Denmark ^[3]

发布时间 2017-05-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交